Ola E. Dahl
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management 73
-
- Atrial Fibrillation Management and Outcomes 52
- Acute Myocardial Infarction Research 28
- Antiplatelet Therapy and Cardiovascular Diseases 15
- Cardiac, Anesthesia and Surgical Outcomes 14
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms 5
- Surgery top 1%
- Hip and Femur Fractures 11
- Orthopaedic implants and arthroplasty 6
- Emergency Medical Services top 1%
- Co-authors
- Bengt I. ErikssonSylvia HaasSam SchulmanFrank MisselwitzAjay K. KakkarClifford W. ColwellCharles W. FrancisCatherine Curley
- Partner nations
- NorwayUnited KingdomGermany
In The Last Decade
Ola E. Dahl
82 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Internal Medicine 5.1k
- Cardiology and Cardiovascular Medicine 4.6k
- Hematology 688
- Surgery 2.1k
- Emergency Medical Services 275
Countries citing papers authored by Ola E. Dahl
This map shows the geographic impact of Ola E. Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola E. Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola E. Dahl more than expected).
Fields of papers citing papers by Ola E. Dahl
This network shows the impact of papers produced by Ola E. Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola E. Dahl. The network helps show where Ola E. Dahl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ola E. Dahl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 28 | |
| 2 | 2019 | 1 | |
| 3 | 2012 | 10 | |
| 4 | 2012 | 17 | |
| 5 | 2012 | 13 | |
| 6 | 2012 | 18 | |
| 7 | Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trialbreakdown → | 2008 | 807 |
| 8 | 2007 | 56 | |
| 9 | 2006 | 5 | |
| 10 | 2005 | 10 | |
| 11 | 2005 | 241 | |
| 12 | 2004 | 22 | |
| 13 | 2003 | 7 | |
| 14 | 2002 | 205 | |
| 15 | Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis against Deep Venous Thrombosis in Patients after Elective Hip Arthroplasty | 2001 | 1 |
| 16 | 2000 | 5 | |
| 17 | 1999 | 3 | |
| 18 | 1995 | 68 | |
| 19 | 1994 | 134 | |
| 20 | 1991 | 3 |
About Ola E. Dahl
Ola E. Dahl is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, Emergency Medical Services and Surgery, having authored 85 papers that have together received 6.3k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (73 papers), Atrial Fibrillation Management and Outcomes (52 papers), Acute Myocardial Infarction Research (28 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Cardiac, Anesthesia and Surgical Outcomes (14 papers), Hip and Femur Fractures (11 papers), Orthopaedic implants and arthroplasty (6 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). The work is most often cited by research in Internal Medicine (5.1k citations), Cardiology and Cardiovascular Medicine (4.6k citations), Hematology (688 citations), Surgery (2.1k citations) and Emergency Medical Services (275 citations). Ola E. Dahl has collaborated with scholars based in Norway, United Kingdom and Germany. Frequent co-authors include Bengt I. Eriksson, Sylvia Haas, Sam Schulman, Frank Misselwitz, Ajay K. Kakkar, Clifford W. Colwell, Charles W. Francis, Catherine Curley, Thomas L. Ortel and Stephen G. Pauker. Their work appears in journals such as Thrombosis Research, Blood, Thrombosis and Haemostasis, International Orthopaedics and Hip International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.